Literature DB >> 18288077

Update: influenza activity--United States, September 30, 2007-February 9, 2008.

.   

Abstract

This report summarizes U.S. influenza activity since the beginning of the 2007-08 influenza season (September 30, 2007) and updates the previous summary. From September through early December, influenza activity remained low in the United States. Activity increased from early December through the end of the year and has continued to increase in January and February.

Mesh：

Substances：

Year:  2008        PMID： 18288077

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  9 in total

1.  5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.

Authors:  Priya Ranjan; Lakshmi Jayashankar; Varough Deyde; Hui Zeng; William G Davis; Melissa B Pearce; John B Bowzard; Mary A Hoelscher; Victoria Jeisy-Scott; Mayim E Wiens; Shivaprakash Gangappa; Larisa Gubareva; Adolfo García-Sastre; Jacqueline M Katz; Terrence M Tumpey; Takashi Fujita; Suryaprakash Sambhara
Journal:  Virol J       Date:  2010-05-21       Impact factor: 4.099

2.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

3.  Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus.

Authors:  Victor C Huber; Loren H Kleimeyer; Jonathan A McCullers
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

4.  A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.

Authors:  Victor C Huber; Paul G Thomas; Jonathan A McCullers
Journal:  Vaccine       Date:  2009-01-07       Impact factor: 3.641

5.  Evolution of H3N2 influenza virus in a guinea pig model.

Authors:  Jinxue Long; Ruth V Bushnell; John K Tobin; Keyao Pan; Michael W Deem; Peter L Nara; Gregory J Tobin
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

6.  Avian Influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways.

Authors:  Margaret A Scull; Laura Gillim-Ross; Celia Santos; Kim L Roberts; Elena Bordonali; Kanta Subbarao; Wendy S Barclay; Raymond J Pickles
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

7.  Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.

Authors:  Joseph T Wu; Gabriel M Leung; Marc Lipsitch; Ben S Cooper; Steven Riley
Journal:  PLoS Med       Date:  2009-05-19       Impact factor: 11.069

8.  Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States.

Authors:  Martha I Nelson; Laurel Edelman; David J Spiro; Alex R Boyne; Jayati Bera; Rebecca Halpin; Naomi Sengamalay; Elodie Ghedin; Mark A Miller; Lone Simonsen; Cecile Viboud; Edward C Holmes
Journal:  PLoS Pathog       Date:  2008-08-22       Impact factor: 6.823

9.  Prevalence of influenza A/H3N2 virus in northern Iran from 2011 to 2013.

Authors:  Mohammadreza Haghshenas; Elham Jafarian; Farhang Babamahmoodi; Ahmad Tabrizi; Sharbano Nandoost; Reza Alizadeh-Navaei
Journal:  Caspian J Intern Med       Date:  2015
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.